Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Antibacterial compounds from Merck act by inhibiting Mur D

Nov. 13, 1998

Compounds for influenza developed at Shionogi

Nov. 12, 1998

New antifungal and antitumor antibiotic produced by Saccharothrix

Nov. 6, 1998

Millennium succeeds in identifying sixth antibacterial target in Wyeth-Ayerst alliance

Nov. 5, 1998

NIAID to sponsor trials of female-controlled topical microbicide; FDA gives green light to study

Nov. 5, 1998

Banyu seeks licensees for new parenteral carbapenems

Nov. 4, 1998

Genvir is as effective as Zovirax in genital herpes, with improved dosing

Nov. 3, 1998

SKB seeks OTC status for penciclovir cream

Oct. 30, 1998

GlycoDesign and NRC agreement represents new approach to antibiotics

Oct. 29, 1998

NDA submitted for new inhaled influenza medication

Oct. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.